A revenue-generating, small-cap Canadian pharmaceutical company
Revenue Projected at $150,000,000 by 2025
Valeo Pharma Inc. Links
Exploring Novel Therapeutic Approaches for COVID-19: Hesperidin vs. Vitamin C
Posted by:
agoracom administrator
on
Jan 12, 2021 07:26AM